Select Publications
Conference Papers
, 2020, 'Pulmonary Arterial Hypertension with Below Threshold Pulmonary Vascular Resistance', in A55. EXERCISE RELATED STUDIES AND CLINICAL STUDIES IN PULMONARY VASCULAR DISEASES, American Thoracic Society, presented at
, 2019, 'Late Breaking Abstract - Validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort', in EUROPEAN RESPIRATORY JOURNAL, EUROPEAN RESPIRATORY SOC JOURNALS LTD, SPAIN, Madrid, presented at
, 2019, 'Interim Results from the Ongoing Open-Label Extension of the Phase 2 Trial Evaluating Ralinepag for the Treatment of Pulmonary Arterial Hypertension', in A105. GLORY DAYS: THE LATEST CLINICAL RESEARCH IN PAH, American Thoracic Society, presented at
, 2017, 'OUTCOMES OF IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION IN THE ERA OF COMBINATION THERAPY: A REPORT FROM THE PHSANZ REGISTRY', in Respirology, Wiley, International Convention Centre, Sydney, Australia, pp. 77 - 78, presented at
, 2017, 'REAL-LIFE VERSUS CLINICAL TRIAL PATIENTS IN PULMONARY ARTERIAL HYPERTENSION: AN ANALYSIS FROM THE PHSANZ REGISTRY', in Respirology, Wiley, pp. 76 - 77, http://dx.doi.org/10.1111/resp.13206_183
, 2017, 'RISE-IIP: Riociguat for the treatment of pulmonary hypertension associated with idiopathic interstitial pneumonia', in Pulmonary Circulation and Pulmonary Vascular Disease, European Respiratory Society, presented at
, 2016, 'Immunosuppression at first hospital discharge after transplantation may not accurately predict risk of cancer in solid organ transplant recipients', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, pp. S316 - S316, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000436953200495&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'Outcomes in Patients Older Than 60 Years of Age Undergoing Orthotropic Heart Transplantation Since Broadening of Eligibility Criteria', in JOURNAL OF HEART AND LUNG TRANSPLANTATION, ELSEVIER SCIENCE INC, DC, Washington, pp. S113 - S113, presented at
, 2016, 'Right Ventricular Performance with Exercise Declines Predictably in Patients with Idiopathic PAH', in JOURNAL OF HEART AND LUNG TRANSPLANTATION, ELSEVIER SCIENCE INC, DC, Washington, pp. S361 - S361, presented at
, 2015, 'Inclusion of Cognitive and Mood Domains in the Assessment of Frailty Enhances Outcome Prediction in Heart Transplant-Eligible Patients With Advanced Heart Failure', in Inclusion of Cognitive and Mood Domains in the Assessment of Frailty Enhances Outcome Prediction in Heart Transplant-Eligible Patients With Advanced Heart Failure, Nice, pp. S181 - S181, presented at
, 2015, 'Frailty as a Predictor of Outcomes in Heart Transplant-Eligible Patients With Advanced Heart Failure', in JOURNAL OF HEART AND LUNG TRANSPLANTATION, ELSEVIER SCIENCE INC, FRANCE, Nice, pp. S187 - S188, presented at
, 2014, 'Risk of Early and Late Non-Hodgkin Lymphoma (NHL) in Australian Liver and Cardiothoracic Transplant Recipients.', in AMERICAN JOURNAL OF TRANSPLANTATION, WILEY-BLACKWELL, CA, San Francisco, pp. 67 - 67, presented at
, 2014, 'RISK OF EARLY AND LATE NON-HODGKIN LYMPHOMA (NHL) IN AUSTRALIAN LIVER AND CARDIOTHORACIC TRANSPLANT RECIPIENTS', in IMMUNOLOGY AND CELL BIOLOGY, NATURE PUBLISHING GROUP, AUSTRALIA, ANU Campus, Canberra, pp. A9 - A9, presented at
, 2014, 'Predicting Peri-operative Right Heart Failure, Post-implant Survival and Timing of Mechanical Ventricular Assistance', in JOURNAL OF HEART AND LUNG TRANSPLANTATION, ELSEVIER SCIENCE INC, CA, San Diego, pp. S58 - S58, presented at
, 2014, 'Renal Impairment Post VAD Implantation in Patients With Normal Pre-operative Renal Function', in JOURNAL OF HEART AND LUNG TRANSPLANTATION, ELSEVIER SCIENCE INC, CA, San Diego, pp. S199 - S200, presented at
, 2014, 'The Impact of Baseline Renal Dysfunction on Patient Outcomes after Implantation of Chronic Mechanical Circulatory Support Devices', in JOURNAL OF HEART AND LUNG TRANSPLANTATION, ELSEVIER SCIENCE INC, CA, San Diego, pp. S200 - S200, presented at
, 2014, 'Cardiac Surgery is Successful in Heart Transplant Recipients', in Heart Lung and Circulation, http://dx.doi.org/10.1016/j.hlc.2014.03.003
, 2013, 'Continuous Flow Left Ventricular Assist Devices Improve Survival in Reactive but Not Fixed Type 2 Pulmonary Hypertension Compared with Medical Therapy', in JOURNAL OF HEART AND LUNG TRANSPLANTATION, ELSEVIER SCIENCE INC, CANADA, Montreal, pp. S232 - S233, presented at
, 2013, 'Risk Factors and Response to Therapy in Heart and Lung Transplant Recipients with Post-Transplant Lymphoproliferative Disease', in JOURNAL OF HEART AND LUNG TRANSPLANTATION, ELSEVIER SCIENCE INC, CANADA, Montreal, pp. S254 - S254, presented at
, 2012, 'Derivation of I-Q Flow Index as a Measure of LV Chamber Function in Patients Supported with Continuous Flow Centrifugal LVADs', in JOURNAL OF HEART AND LUNG TRANSPLANTATION, ELSEVIER SCIENCE INC, CZECH REPUBLIC, Prague, pp. S49 - S49, presented at
, 2012, 'Early Clinical Experience Supplementing Celsior Preservation Solution with Pro-Survival Kinase Agents Glyceryl Trinitrate and Erythropoietin Demonstrates Improved Myocardial Recovery Post Cardiac Transplantation', in JOURNAL OF HEART AND LUNG TRANSPLANTATION, ELSEVIER SCIENCE INC, CZECH REPUBLIC, Prague, pp. S149 - S150, presented at
, 2012, 'Severe Acute Kidney Injury Is the Most Powerful Predictor of Mortality after Heart Transplantation', in JOURNAL OF HEART AND LUNG TRANSPLANTATION, ELSEVIER SCIENCE INC, CZECH REPUBLIC, Prague, pp. S234 - S234, presented at
, 2012, 'Veno-Pulmonary Arterial ECMO as Temporary Right Ventricular Support in Patients Undergoing Left Ventricular Assist Device Implantation', in JOURNAL OF HEART AND LUNG TRANSPLANTATION, ELSEVIER SCIENCE INC, CZECH REPUBLIC, Prague, pp. S201 - S202, presented at
, 2011, 'An Open-Label Extension Trial Of UT-15C SR In Subjects With Pulmonary Arterial Hypertension -- Interim Results Of Patients From Freedom - C', in D33. PULMONARY HYPERTENSION: TREATMENT, American Thoracic Society, presented at
, 2011, 'Symptoms To Definitive Diagnosis Of Pulmonary Arterial Hypertension (PAH)', in A60. PULMONARY HYPERTENSION: DIAGNOSIS, American Thoracic Society, presented at
, 2009, 'ARIES-3: Ambrisentan Therapy in a Diverse Population of Patients with Pulmonary Hypertension.', in B55. PULMONARY HYPERTENSION -- CLINICAL, American Thoracic Society, presented at
, 2009, 'Results of the FREEDOM–C Study: A Pivotal Study of Oral Treprostinil Used Adjunctively with an ERA and/or PDE5-Inhibitor for the Treatment of PAH.', in A17. TREATMENT OF PAH, American Thoracic Society, presented at
, 2008, 'De Novo concentration-controlled everolimus is associated with a decreased incidence of CMV infection in cardiac transplant recipients', in Journal of Heart and Lung Transplantation, Elsevier Science Inc, New York, NY, USA, pp. S66 - S66, presented at
, 2008, 'Impact of de novo everolimus-based immunosuppression on wound healing and tissue regeneration in heart transplantation', in Journal of Heart and Lung Transplantation, Elsevier Science Inc, New York, NY, USA, pp. S118 - S118, presented at
, 1999, 'GTN induced change of radial pressure pulse contour in cardiomyopathic patients', in Japanese Journal of Clinical Pharmacology and Therapeutics, pp. 141 - 142, http://dx.doi.org/10.3999/jscpt.30.141
, 1999, 'Increase in expression of P(2X1) receptors in the atria of patients suffering from dilated cardiomyopathy', in Electrophoresis, pp. 2059 - 2064, http://dx.doi.org/10.1002/(SICI)1522-2683(19990701)20:10<2059::AID-ELPS2059>3.0.CO;2-T
, 1998, 'Carvedilol in elderly heart failure patients', in Australian and New Zealand Journal of Medicine, Adis International Limited, Frenchs Forest, NSW, pp. 151 - 151, presented at
, 1998, 'Clinical experience with transmyocardial laser revascularisation in Class IV angina', in Australian and New Zealand Journal of Medicine, Adis International Limited, Frenchs Forest, NSW, pp. 117 - 117, presented at
, 1998, 'Coenzyme Q10 in Class II and III heart failure', in Australian and New Zealand Journal of Medicine, Adis International Limited, Frenchs Forest, NSW, pp. 151 - 151, presented at
, 1998, 'Inotropic therapy improves neuroendocrine abnormalities in severe heart failure', in Australian and New Zealand Journal of Medicine, Adis International Limited, Frenchs Forest, NSW, pp. 174 - 174, presented at
, 1998, 'Interim analysis of a randomised trial of cardiomyoplasty against optimal medical therapy in Class III heart failure', in Australian and New Zealand Journal of Medicine, Adis International Limited, Frenchs Forest, NSW, pp. 174 - 174, presented at
, 1998, 'Long-term followup of patients randomised to exercise training and cardiac rehabilitation in moderate heart failure', in Australian and New Zealand Journal of Medicine, Adis International Limited, Frenchs Forest, NSW, pp. 150 - 150, presented at
, 1998, 'Measurement of pulmonary vascular resistance in children with end-stage cardiomyopathy', in Australian and New Zealand Journal of Medicine, Adis International Limited, Frenchs Forest, NSW, pp. 153 - 153, presented at
, 1998, 'Ten year followup of a double versus triple therapyt trial after cardiac transplantation', in Australian and New Zealand Journal of Medicine, Adis International Limited, Frenchs Forest, NSW, pp. 174 - 174, presented at
, 1998, 'Tolerability of variable positive airway pressure on pulmonary hemodynamics in patients with congestive cardiac failure', in Australian and New Zealand Journal of Medicine, Adis International Limited, Frenchs Forest, NSW, pp. 181 - 181, presented at
, 1998, 'Alterations in the expression of P(2X1) receptors in failing and nondiseased human atria', in Electrophoresis, pp. 856 - 859, http://dx.doi.org/10.1002/elps.1150190542
, 1998, 'Correlation between invasive and non-invasive measurement of pulmonary arterial pressure in advanced heart failure', in Australian New Zealand JournalMedicine, Australian New Zealand Journal of Medicine 1998, pp. 1:113 - 1:113, presented at
, 1998, 'Estimation of cardiac function by non-invasive tonometric measurements of the radial pulse pressure contours in cardiomyopathic patients', in Australian and New Zealand Journal of Medicine, Adis International Limited, Frenchs Forest, NSW, pp. 1:114 - 1:114, presented at
, 1998, 'Success of cardioversion and low dose amiodarone in patients with chronic atrial fibrillation and congestive cardiac failure', in Australian and New Zealand Journal of Medicine, Adis International Limited, Frenchs Forest, NSW, pp. 1:82 - 1:82, presented at
, 1998, 'Ten year followup of a double versus triple therapy trial after cardiac transplantation', in Australian JournalPharmacy, J Heart Lung Transplant, pp. 1:75 - 1:75, presented at
, 1998, 'The impact of concurrent amiodarone therapy on the response to carvedilol in heart failure', in Australian New Zealand JournalMedicine, Australian New Zealand Journal of Medicine 1998, pp. 1:121 - 1:121, presented at
, 1998, 'The pathology of the transmyocardial laser revascularisation procedure', in Australian JournalPharmacy, J Heart Lung Transplant, pp. 1:46 - 1:46, presented at
, 1998, 'Tolerability and efficacy of carvedilol in NYHA Class IV heart failure', in Australian New Zealand JournalMedicine, Australian New Zealand Journal of Medicine 1998, pp. 1:117 - 1:117, presented at
, 1997, 'The impact of concurrent amiodarone therapy on the response to carvedilol in heart failure', in CIRCULATION, AMER HEART ASSOC, pp. 3234 - 3234, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997YC88003215&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 1997, 'Tolerability and efficacy of carvedilol in NYHA Class IV heart failure', in CIRCULATION, AMER HEART ASSOC, pp. 3227 - 3227, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997YC88003208&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1